Catherine Harmer is a Professor of Cognitive Neuroscience at the University Department of Psychiatry in Oxford. She directs a multidisciplinary team of researchers in the Psychopharmacology and Emotion Research Lab (PERL) using a variety of techniques such as fMRI, MEG, TMS, psychopharmacological challenge techniques and neuropsychological assessments in healthy volunteers and patients with depression.  Her work has led to the novel idea that antidepressants may work by rapidly resolving negative affective bias in depression which leads to gradual improvements in mood, social dysfunction and other key symptoms of depression over time.  This concept  has stimulated new research approaches for the treatment of depression with implications for stratification of treatment, early prediction of therapeutic response and identification of novel therapeutic targets. Catherine Harmer sits on the Executive Committee of the ECNP. the Wellcome Trust Expert Review Group (neuroscience and mental health) and on the BAP council (2007-2013). Catherine Harmer has been awarded prizes from the British Association for Psychopharmacology and the Royal College of Psychiatrists for this research and is the 2013 recipient of the A E Bennett award from the Society of Biological Psychiatry.